This grant aims to reduce the duration of untreated psychosis (DUP) in the US by improving early identification and referral to Coordinated Specialty Care (CSC) services for individuals experiencing a first episode of psychosis (FEP). The focus is on identifying baseline DUP rates, mapping referral pathways to CSC care, addressing bottlenecks in the care process, and testing strategies to shorten DUP to meet WHO recommendations. Funding is available for planning research projects that aim to improve outcomes associated with schizophrenia and related psychotic disorders by intervening in the critical early phase of psychotic illness.
Opportunity ID: 314458
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | PAR-19-235 |
| Funding Opportunity Title: | Reducing the Duration of Untreated Psychosis in the United States (R34 Clinical Trial Required) |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Grant |
| Category of Funding Activity: | Health |
| Category Explanation: | – |
| Expected Number of Awards: | – |
| Assistance Listings: | 93.242 — Mental Health Research Grants |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | Apr 02, 2019 |
| Last Updated Date: | Apr 02, 2019 |
| Original Closing Date for Applications: | May 07, 2022 |
| Current Closing Date for Applications: | May 07, 2022 |
| Archive Date: | Jun 12, 2022 |
| Estimated Total Program Funding: | – |
| Award Ceiling: | $225,000 |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | Public and State controlled institutions of higher education City or township governments Native American tribal governments (Federally recognized) Public housing authorities/Indian housing authorities Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education State governments County governments Native American tribal organizations (other than Federally recognized tribal governments) Small businesses For profit organizations other than small businesses Special district governments Others (see text field entitled “Additional Information on Eligibility” for clarification) Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Private institutions of higher education Independent school districts |
| Additional Information on Eligibility: | Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are allowed. |
Additional Information
| Agency Name: | National Institutes of Health |
| Description: | Approximately 100,000 adolescents and young adults in the United States experience a first episode of psychosis (FEP) every year. The early phase of psychotic illness is widely viewed as a critical opportunity for indicated prevention, and a chance to alter the downward trajectory and poor outcomes associated with schizophrenia and related psychotic disorders. Unfortunately, numerous studies find a substantial delay between the onset of psychotic symptoms and the initiation of FEP care; in the U.S. treatment is typically delayed between one and three years. Early identification of FEP, rapid referral to evidence-based Coordinated Specialty Care (CSC) for early psychosis, and effective engagement in CSC services are essential to shortening the duration of untreated psychosis (DUP) and pre-empting the functional deterioration common in psychotic disorders. The World Health Organization advocates reducing DUP to 3 months or less. Accordingly, this Funding Opportunity Announcement (FOA) seeks planning research project grant applications that (1) identify a baseline rate of DUP in community or institutional settings; (2) map referral pathways to CSC care, (3) identify bottlenecks and gaps in the pathway to CSC care, and (4) develop and pilot test feasible strategies for substantially reducing DUP among persons with FEP. |
| Link to Additional Information: | http://grants.nih.gov/grants/guide/pa-files/PAR-19-235.html |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV Email:FBOWebmaster@OD.NIH.GOV |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
Related Documents
Folder 314458 Full Announcement-PAR-19-235 -> PAR-19-235-Full-Announcement.pdf
Packages
| Agency Contact Information: | NIH OER Webmaster FBOWebmaster@OD.NIH.GOV Email: FBOWebmaster@OD.NIH.GOV |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| FORMS-E | Use for due dates on or before May 24, 2020 | PKG00249624 | May 16, 2019 | May 24, 2020 | View | |
| FORMS-F | Use for due dates on or before January 24, 2022 | PKG00260095 | May 16, 2019 | Jan 24, 2022 | View | |
| FORMS-G | Use for due dates on or after January 25, 2022 | PKG00272312 | Feb 28, 2022 | May 07, 2022 | View |
Package 1
Mandatory forms
314458 RR_SF424_2_0-2.0.pdf
314458 PHS398_CoverPageSupplement_4_0-4.0.pdf
314458 RR_OtherProjectInfo_1_4-1.4.pdf
314458 PerformanceSite_2_0-2.0.pdf
314458 RR_KeyPersonExpanded_2_0-2.0.pdf
314458 PHS398_ResearchPlan_4_0-4.0.pdf
Optional forms
314458 RR_Budget_1_4-1.4.pdf
314458 RR_SubawardBudget30_1_4-1.4.pdf
314458 PHS398_ModularBudget_1_2-1.2.pdf
314458 PHS_AssignmentRequestForm_2_0-2.0.pdf
Package 2
Mandatory forms
314458 RR_SF424_2_0-2.0.pdf
314458 PHS398_CoverPageSupplement_5_0-5.0.pdf
314458 RR_OtherProjectInfo_1_4-1.4.pdf
314458 PerformanceSite_2_0-2.0.pdf
314458 RR_KeyPersonExpanded_2_0-2.0.pdf
314458 PHS398_ResearchPlan_4_0-4.0.pdf
314458 PHSHumanSubjectsAndClinicalTrialsInfo_2_0-2.0.pdf
Optional forms
314458 RR_Budget_1_4-1.4.pdf
314458 RR_SubawardBudget30_1_4-1.4.pdf
314458 PHS398_ModularBudget_1_2-1.2.pdf
314458 PHS_AssignmentRequestForm_3_0-3.0.pdf
Package 3
Mandatory forms
314458 RR_SF424_5_0-5.0.pdf
314458 PHS398_CoverPageSupplement_5_0-5.0.pdf
314458 RR_OtherProjectInfo_1_4-1.4.pdf
314458 PerformanceSite_4_0-4.0.pdf
314458 RR_KeyPersonExpanded_4_0-4.0.pdf
314458 PHS398_ResearchPlan_4_0-4.0.pdf
314458 PHSHumanSubjectsAndClinicalTrialsInfo_3_0-3.0.pdf
Optional forms
314458 RR_Budget_3_0-3.0.pdf
314458 RR_SubawardBudget30_3_0-3.0.pdf
314458 PHS398_ModularBudget_1_2-1.2.pdf
314458 PHS_AssignmentRequestForm_3_0-3.0.pdf
Share This Post, Choose Your Platform!
About the Author: osnqt
